A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
M W RudolphJ B Dressman

Abstract

The aim of the present study was to develop a multi-unit dosage form containing 5-aminosalicylic acid (5-ASA) for the treatment of ulcerative colitis (UC), optimised on the basis of recent studies indicating that UC patients have higher intestinal pH than was previously thought to be the case. Pellets with a drug content of 77.4% were prepared by a granulation and spheronization process and then coated with a new pH sensitive poly(meth)acrylate copolymer (Eudragit((R)) FS 30D) to achieve site specific drug release close to the ileocecal valve. Dissolution tests were carried out in a paddle dissolution apparatus in media simulating pH conditions at various locations in the gastrointestinal tract. The pellets released rapidly at pH values above 7.5. Between 6.8 and 7.2 drug release was found to be zero order, while at pH 6.5 and below no release occurred. In a biorelevant medium which simulates the fasting proximal small intestine fluid it was shown that neither surfactants (sodium taurocholate and lecithin) nor changes in ionic strength trigger drug release. Compared to 5-ASA pellets coated with the well established Eudragit((R)) S, and to currently marketed products licensed for the treatment of UC, the multi-unit dosage form c...Continue Reading

References

May 1, 1995·Biomaterials·A R Khare, N A Peppas
Jan 1, 1994·Journal of Drug Targeting·M Ashford, J T Fell
Nov 1, 1993·Digestive Diseases and Sciences·J FallingborgS N Rasmussen
Aug 13, 1998·Alimentary Pharmacology & Therapeutics·A G PressG Ramadori
Mar 4, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Z KhanN Kurjaković
Apr 1, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·S DavaranA Khosravi

❮ Previous
Next ❯

Citations

Apr 12, 2008·Pharmaceutical Research·Ekarat JantratidJennifer B Dressman
Nov 7, 2001·Current Gastroenterology Reports·P Y Chung, R D Cohen
May 17, 2005·International Journal of Pharmaceutics·Nathalie HuyghebaertJean Paul Remon
Jun 4, 2013·International Journal of Pharmaceutics·Alessandra MaroniAndrea Gazzaniga
Jul 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf LamprechtYoshiaki Kawashima
Mar 7, 2002·International Journal of Pharmaceutics·Libo YangJoseph A Fix
Sep 9, 2010·Molecular Pharmaceutics·Deanna M MudieGregory E Amidon
Nov 26, 2009·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Ashley M AimoneDeborah L O'Connor
Sep 16, 2005·Drugs·Abdul W Basit
Mar 20, 2015·Drug Delivery and Translational Research·Rajkumar MalayandiDeepika Aggarwal
Oct 1, 2014·Colloids and Surfaces. B, Biointerfaces·Muhammad NaeemJin-Wook Yoo
Mar 23, 2011·Drug Development and Industrial Pharmacy·Tereza BautzováAlf Lamprecht
Aug 28, 2007·Journal of Pharmaceutical Sciences·John A SpencerAjaz Husain
Jul 22, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Emma L McConnellAbdul W Basit
Apr 25, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fatmanur Tuğcu-DemirözOznur Konuş-Boyunağa
Sep 24, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Cord J AndreasJennifer Dressman
Jun 13, 2012·The Journal of Pharmacy and Pharmacology·Grzegorz Garbacz, Sandra Klein
Jul 13, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf LamprechtYoshiaki Kawashima
Jun 23, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Alf LamprechtYoshiaki Kawashima
Jun 30, 2006·International Journal of Pharmaceutics·Chunsheng GaoXingguo Mei
Dec 17, 2005·International Journal of Pharmaceutics·Valentine C IbekweAbdul W Basit
Mar 19, 2005·Drug Development and Industrial Pharmacy·A IruínM A Holgado
Jul 28, 2004·Alimentary Pharmacology & Therapeutics·C BottJ Stein
Mar 23, 2011·Drug Development and Industrial Pharmacy·S KrenzlinJ Siepmann
Jun 18, 2004·Drug Delivery·M K Chourasia, S K Jain
Sep 5, 2006·Expert Opinion on Drug Delivery·Andrea GazzanigaLucia Zema
Nov 22, 2005·Expert Opinion on Drug Delivery·Filippos Kesisoglou, Ellen M Zimmermann
Sep 30, 2008·Pharmaceutical Development and Technology·Monica C ChuongJames W Ayres
May 18, 2012·Pharmaceutical Development and Technology·Shivaan CooppanViness Pillay
Oct 7, 2010·Pharmaceutical Development and Technology·Chien NguyenJames W Ayres
Jun 23, 2005·The Journal of Pharmacy and Pharmacology·Sandra KleinJennifer Dressman
Dec 29, 2012·International Journal of Biological Macromolecules·Kuldeep SinghVikas Rana
Jul 17, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fotios BaxevanisNikoletta Fotaki
Oct 9, 2012·International Journal of Pharmaceutics·Rouslan I MoustafineGuy Van den Mooter
Apr 11, 2008·Drug Development and Industrial Pharmacy·Alireza GhaffariMorteza Rafiee-Tehrani
Jul 3, 2010·Expert Review of Clinical Immunology·Arik DahanEllen M Zimmermann
Apr 2, 2009·Drug Development and Industrial Pharmacy·S J KshirsagarR P Pawar
Sep 11, 2009·Drug Development and Industrial Pharmacy·Ehab R BendasJames W Ayres
Jun 12, 2012·Pharmaceutical Development and Technology·Yellela S R Krishnaiah, Mansoor A Khan
Jan 12, 2017·AAPS PharmSciTech·Rodrigo Gomes de AlencarRicardo Neves Marreto
Sep 29, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Roberta L KellerJeffrey R Fineman
Dec 15, 2010·Journal of Polymer Science. Part A, Polymer Chemistry·Youngmi Kim, Kathryn E Uhrich
May 3, 2014·Cardiology in the Young·Gwen Y AltonUNKNOWN Western Canadian Pediatric Therapies Follow-Up Group
May 18, 2013·Cardiology in the Young·Patrick Michael Emmet NoonanOliver Stumper
Jan 7, 2020·Pharmaceutical Development and Technology·Fernanda Belincanta Borghi-PangoniMarcos Luciano Bruschi
May 23, 2015·Pharmaceutical Development and Technology·Michal ŠimekBohumil Kratochvíl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.